AstraZeneca nối lại thử nghiệm vắcxin ngừa COVID-19

(TTXVN/Vietnam+) 08:15 14/09/2020

Ngày 12/9, hãng dược phẩm liên doanh Anh-Thụy Điển AstraZeneca đã thông báo nối lại thử nghiệm lâm sàng theo cách thức ngẫu nghiên đối với vắcxin AZD1222 - một trong những loại vắcxin được đánh giá có tiềm năng nhất ngừa bệnh viêm đường hô hấp cấp COVID-19 hiện nay.

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